AstraZeneca nối lại thử nghiệm vắcxin ngừa COVID-19

(TTXVN/Vietnam+) 08:15 14/09/2020

Ngày 12/9, hãng dược phẩm liên doanh Anh-Thụy Điển AstraZeneca đã thông báo nối lại thử nghiệm lâm sàng theo cách thức ngẫu nghiên đối với vắcxin AZD1222 - một trong những loại vắcxin được đánh giá có tiềm năng nhất ngừa bệnh viêm đường hô hấp cấp COVID-19 hiện nay.

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